MRI scans are strong diagnostics with high-definition images of what lies inside a body. Strong magnetic fields require precaution, as brought out by an instance where a young woman suffered very serious injuries due to an oversight in a metallic core within a silicone sex toy that she happened to have before the MRI scan. This makes a stark reminder about the potentially deadly consequences of missing metal objects when such procedures are being performed. In April 2023, a 23-year-old woman went into an MRI with a silicone plug containing a metal core that was not known.

She thought that the item is made entirely out of silicone according to the advertising. However, the strong magnetic field of the MRI machine interacted with the hidden metal, dragging the object through her body and causing excruciating pain. According to reports from the U.S. Food and Drug Administration (FDA), the scene was harrowing, with the woman screaming in agony and requiring immediate hospitalization. Despite pre-scan screenings, which are routine prior to a scan, the patient did not inform the facility that the object existed because he presumed it was purely non-metallic. This caused serious injuries that led to the patient's law suit against the manufacturer for deceitful misrepresentations of material content.

MRI machines employ magnets between 0.5 to 3 Tesla (T). This is thousands of times stronger than the Earth's magnetic field. The tremendous force causes ferromagnetic materials, like iron and nickel, to be magnetized quickly and become strongly attracted toward the magnet. Objects as small as hairpins or paper clips will accelerate at 40 miles per hour inside the magnetic field.

The force can lead to catastrophic injuries in items lodged within the body, such as metallic implants or foreign objects. Metallic cores within devices, like pacemakers or intrauterine devices, must be disclosed to radiologists to prevent such complications.

How Metal Objects Interact with MRI Fields?

On these claims, Dr. Adam Taylor, a specialist in human anatomy, weighed his words in a international health website and added that the distance away and mass of this object would increase its velocity towards that of sound, "The acceleration would be phenomenal, but with a metallic core, it can't go anywhere near supersonic speeds. As for the size, the magnetic acceleration to the internal soft tissues would ensure that there could be severe intracranial trauma."

The injuries inflicted in this case likely involved damage to major blood vessels, nerves, or organs, highlighting the devastating impact of even minor oversight during an MRI scan.

This is not an isolated case. There are documented cases of metallic objects causing serious damage during MRI scans with a 65-year-old man with schizophrenia swallowed metal objects, including sockets and a hinge pin. The powerful magnetic field during an MRI scan caused the objects to rupture his stomach, resulting in serious injuries.

A toddler who ingested 11 small magnets perforated his bowel while undergoing a scan, making his case unique. In another deadly but extremely rare incident, there have been people who hide a firearm on themselves during MRI procedures. Magnetic attraction can trigger a discharge in a weapon and has led to some fatal injuries.

These cases emphasize the very strong need for adequate screening and patient education prior to an MRI.

Preventing MRI-Related Incidents

Medical professionals have been trained to avoid risks. This is by properly screening a patient for metallic objects. In general, most pre-scan protocols include:

• Patients are interrogated about implants, recent surgery or exposures at work related to metals.
• Radiologists sometimes use handheld metal detectors to search for hidden items.
• People who work with metal, like welders or machinists, will need additional testing to detect microscopic metal fragments within soft tissues or eyes.

The case emphasizes the importance of product labeling by manufacturers, especially those products that are likely to unintentionally cause harm to health. The patient's assumption that her device was 100% silicone points to a larger problem in consumer markets with misinformation.

It also reminds the patients to report any possible dangers to the medical professionals, no matter how the objects look non-metallic. In sensitive cases, patients can request private discussions with healthcare providers to ensure safety without discomfort.

In the end, it is a joint effort from manufacturers, healthcare professionals, and patients that can prevent such tragedies. Manufacturers must ensure truthful marketing, while healthcare providers should educate patients about the dangers of metal objects in MRI settings. For patients, understanding the risks and actively participating in pre-scan disclosures can be lifesaving.

This young woman's experience is a sobering example of the unforeseen dangers posed by MRI machines when precautions are overlooked. It serves as a wake-up call to address gaps in patient awareness, medical protocols, and product transparency. By learning from this incident, the medical community and the public can work together to ensure MRI scans remain a safe and effective diagnostic tool.

Brazilian authorities on Wednesday approved the world’s first single-dose dengue vaccine, describing it as a “historic” step amid a global surge in cases fueled by rising temperatures. Dengue, which causes severe flu-like symptoms, extreme fatigue, and body aches, hit record global levels in 2024, with scientists linking its rapid spread to climate change. Brazil’s health regulatory body ANVISA cleared the use of Butantan-DV, created by the Butantan Institute in São Paulo, for individuals aged 12 to 59.

Until now, the only dengue vaccine available globally was TAK-003, which requires two doses spaced three months apart, according to the World Health Organization (WHO). Here’s everything currently known about this single-dose vaccine.

Also Read: GRAP 3 Restrictions Revoked In Delhi-NCR: What Residents Can Use Again And What Stays Restricted

Dengue Single Dose Vaccine Approved In Brazil

On Wednesday, November 26, Anvisa approved the world’s first single-dose dengue vaccine. The announcement followed the signing of a term considered the final step in registering the vaccine, produced entirely at a national laboratory, during a press conference, as reported by CNN Brazil. The development of Butantan-DV is the result of collaboration between Brazil’s Ministry of Health, the Butantan Institute, and the Chinese lab Wu Xi.

Butantan-DV: All You Need To Know About The Single Dose Dengue Vaccine

Anvisa stated that the new vaccine uses live attenuated virus technology and is currently approved for people aged 12 to 59—a range that could expand if new studies support it. The Ministry of Health will determine the official vaccination start date and the target age group. The registration request for the vaccine was submitted by the Butantan Institute in January 2025. Anvisa fast-tracked its evaluation, forming a technical panel that included external experts to review the process.

What Is A Live Attenuated Virus?

A live attenuated virus is a weakened form of a virus used in vaccines to trigger a strong and lasting immune response without causing the full-blown disease. These viruses are developed in a lab, often through repeated culturing, so they can replicate in the body but only in a limited way. By closely mimicking a natural infection, they prompt the immune system to respond similarly to how it would during a real infection, according to the U.S. Department of Health and Human Services.

Also Read: CDC To Appoint Vaccine-Skeptic Surgeon Ralph Abraham As Deputy Director

How Effective Is This Single Dose Dengue Vaccine?

CNN Brazil reported that the Ministry of Health found the vaccine to have an overall efficacy of 74.7% against symptomatic dengue for people aged 12 to 59. This means that nearly three out of four people were protected from the disease. Protection was similar for those who had previously had dengue and those who were never exposed to the virus.

In 2024, over 14 million dengue cases were reported globally, marking a record year, according to ScienceDirect and WHO. The death toll reached more than 9,500. While the Americas reported the highest number of cases, dengue continues to affect more than 100 countries worldwide.

Dengue, often called “breakbone fever” because of its intense symptoms, can in severe cases lead to hemorrhagic fever and even death. The disease spreads through infected Aedes mosquitoes, which are now appearing in areas beyond their traditional habitats, resulting in dengue cases in parts of Europe and the United States where it was previously uncommon.

The Commission for Air Quality Management (CAQM) on Wednesday lifted the Stage 3 restrictions of the Graded Response Action Plan (GRAP) in Delhi NCR after the region saw a steady improvement in air quality over the past three days. Delhi’s 24 hour average Air Quality Index (AQI) was recorded at 327, and forecasts from the India Meteorological Department and the Indian Institute of Tropical Meteorology indicate that the air is expected to stay in the very poor range.

Even with this slight relief, the Commission noted that measures under Stage 1 and Stage 2 of the revised GRAP, notified on November 21, will remain active. These curbs will be tracked closely across the National Capital Region to prevent pollution levels from rising again.

Also Read: Mounjaro Users Face Higher Weight And Diabetes Risk After Halting Injections, Study Says

GRAP 3 Restrictions Revoked in Delhi NCR: What Restrictions Are Lifted?

With Stage 3 now withdrawn, the rule that required offices to operate with half their staff working from home has ended, and schools are no longer expected to follow hybrid classes. Delhi Environment Minister Manjinder Singh Sirsa confirmed this in a post on X.

Previously, the Delhi government had instructed its departments and private workplaces to keep only 50 per cent of employees on site while the rest worked remotely.

Here is what continues under GRAP I and GRAP II.

Also Read: CDC To Appoint Vaccine-Skeptic Surgeon Ralph Abraham As Deputy Director

Restrictions under GRAP I

GRAP Stage 1 calls for the following steps in Delhi:

• Strict checks on vehicles that pollute, smoother traffic flow, and emission controls in units such as industries, power plants and brick kilns.
• A ban on open waste burning, limits on the use of diesel generators, and a stop on using coal or firewood in eateries.
• Public transport stays fully operational, with people encouraged to choose it over personal vehicles.

GRAP Stage II involves the use of mechanised road sweepers, anti smog guns, and daily water sprinkling to reduce dust and particulate matter.

Restrictions under GRAP II

These are the curbs under GRAP Stage 2:

• Ban on coal and firewood use in Delhi.
• Diesel generators cannot be used unless needed for essential or emergency services.
• Construction and demolition sites and industrial units facing specific closure orders are not allowed to restart activity.

GRAP 3 Curbs Lifted But AQI Remains In Very Poor Category

Air quality in Delhi and surrounding areas stayed at troubling levels on Wednesday. The morning AQI was 371, which falls in the very poor category. This was an improvement from 420 at the same time on Tuesday, according to readings from the air quality platform aqi.in.

During winter, Delhi NCR enforces GRAP-based restrictions depending on the air quality level. The plan divides pollution levels into four stages. Stage 1 is Poor with an AQI of 201 to 300. Stage 2 is Very Poor with an AQI of 301 to 400. Stage 3 is Severe with an AQI of 401 to 450. Stage 4 is Severe Plus with an AQI above 450. Cold conditions, along with emissions from vehicles, stubble burning, firecrackers, and other local sources, often push the region into unhealthy air quality during this season.

Health benefits gained from using popular weight loss injection Mounjaro are reversed when patients stop taking the jab, a new study has suggested. The medication, which contains tirzepatide, is often called the “King Kong” of weight loss shots, with earlier research showing it can help people lose up to 25 per cent of their body weight in about 18 months. A new study now reports that once patients discontinue the jab, many put weight back on and also lose other gains, such as lower blood pressure and improved levels of unhealthy cholesterol.

The research, published in Jama Internal Medicine, tracked 308 people who had lost weight and seen improvements in several health markers during their course of tirzepatide.

Also Read: The Risk You Didn't Know: Delhi's Toxic Air Can Also Impact Your Blood Health

Health Benefits Of Mounjaro Reverses When Jabs Halted

According to The Independent, the team found that after the group stopped the medication, 82 per cent of the participants regained 25 per cent or more of the weight they had previously lost. Those who gained weight again also saw their blood pressure and cholesterol return towards earlier levels that had improved during treatment.

“Higher weight regain on withdrawal of tirzepatide was associated with a greater reversal of improvements in cardiometabolic parameters achieved with tirzepatide treatment,” the Surmount 4 researchers wrote. “These findings support the need for continued obesity treatment in adults living with obesity.”

Earlier this year, the National Institute for Health and Care Excellence said many people tend to regain weight if they do not receive proper support after stopping weight loss medicines. This followed new work published in BMC Medicine that observed a wider pattern of weight returning once treatment courses ended.

Nice stressed the value of building long term habits, using self tracking tools and drawing on different forms of support, from online groups to family based help and local activities. “Successful weight management does not end when medication stops or when someone completes a behavioural programme,” said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice.

Also Read: CDC To Appoint Vaccine-Skeptic Surgeon Ralph Abraham As Deputy Director

“We know the period after treatment is vital, and people need steady support to hold on to the progress they have made. This new standard ensures services offer that continuity of care, and it helps the NHS 10 Year Plan move towards a model that places greater focus on prevention instead of illness.”

Mounjaro Benefits Including Weight Loss Are Reversed When Use Stops: Why This Happens?

Excess weight is closely tied to higher blood pressure, unhealthy cholesterol trends and weaker glucose control. Professor Naveed Sattar, a cardiometabolic expert involved in earlier phases of the Surmount programme, explained that it is understandable to see these risk factors rise when weight returns. The quicker and more fully the weight comes back, the more these risks tend to climb. In short, tirzepatide does not create a lasting reset. While the medicine is taken and weight is lower, health markers improve. When treatment ends and weight rises again, those improvements fade.

What This Means If You Are Using Mounjaro Or A Similar Medicine?

For many people, the findings underline that obesity is a long-term condition rather than a short-term task. Medicines that influence appetite and hormones work while they remain part of treatment. When they are stopped, the body often drifts back towards its earlier weight, especially if past eating patterns and activity levels return. If you are using tirzepatide or a related medicine and are considering stopping, it is important to discuss this with your diabetes or weight management team so that your next steps are supported properly.